Search

everythinglearnresearchcommunity

for

Search:↓

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Injecting certain cells into mice caused hair loss, which was preventable with a specific inhibitor.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Vitiligo and alopecia areata may have similar causes despite their differences.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Alopecia areata may be caused by the immune system attacking hair follicles.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

A new mouse model for vitiligo helps study immune responses and potential treatments.

New therapies like JAK inhibitors, PRP, and stem cell treatments show promise for better alopecia management.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Intralesional corticosteroids effectively treat localized alopecia areata, often sparing white hairs.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Blocking IL-17 signaling can delay skin aging and improve skin and hair health.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

The immune system can cause permanent skin and hair whitening by attacking pigment cells.

IL-27 may help prevent hair loss by creating immune-suppressing cells.